Menon A G, Gusella J F, Seizinger B R
Molecular Neurogenetics Laboratory, Massachusetts General Hospital, Boston 02114.
Cancer Surv. 1990;9(4):689-702.
The locus for the gene causing neurofibromatosis type 1 (NF1) was bracketed to a region on the long arm of chromosome 17 by means of genetic linkage analysis. When the limits of resolution for genetic mapping were reached physical mapping methods were used to map the NF1 gene precisely, with reference to translocation breakpoints in NF1 affected individuals who harboured constitutional chromosomal translocations on chromosome 17. The region of DNA located between two translocation breakpoints has been cloned and a DNA sequence encoding a 11-13 kb mRNA identified. That this sequence shows deletions and point mutations in NF1 affected individuals and not in normal controls provides strong evidence that it is indeed the NF1 gene. The genetic defect in NF2 has been mapped to chromosome 22 by studies of chromosomal loss in tumours associated with this disease. Subsequent linkage analysis of NF2 pedigrees has confirmed this location. DNA markers that bracket the NF2 locus to a region of 5-10 Mb have been identified.
通过遗传连锁分析,将导致1型神经纤维瘤病(NF1)的基因位点定位于17号染色体长臂上的一个区域。当遗传图谱的分辨率达到极限时,采用物理图谱绘制方法,参照17号染色体上存在结构染色体易位的NF1患者的易位断点,精确绘制NF1基因图谱。位于两个易位断点之间的DNA区域已被克隆,并鉴定出一个编码11 - 13 kb mRNA的DNA序列。该序列在NF1患者中显示有缺失和点突变,而在正常对照中未出现,这有力地证明它确实是NF1基因。通过对与该疾病相关肿瘤的染色体缺失研究,已将NF2的遗传缺陷定位于22号染色体。随后对NF2家系的连锁分析证实了这一位置。已鉴定出将NF2基因位点限定在5 - 10 Mb区域的DNA标记。